Article II: Volume, clearance, and half-life

Journal of the American Veterinary Medical Association

Volumn 213, Issue 8, 1998, Pages 1122-1127

  Martinez, Marilyn N ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HALF LIFE TIME; METABOLIC CLEARANCE RATE; PHARMACOKINETICS; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; HALF-LIFE; METABOLIC CLEARANCE RATE; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 0032531542     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Baggot JD. Principles of drug disposition in domestic animals: the basis of veterinary clinical pharmacology. Philadelphia: WB Saunders Co, 1977.
2. Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics, 3rd ed. Norwalk, Conn: Appleton and Lange Publishers, 1993.
3. Ritschel WA, Hammer GV. Predication of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption. Int J Clin Pharmacol Ther Tox 1980;18:298-316.
4. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. Philadelphia: Lea & Febiger, 1995.
5. Riviere JE. Veterinary clinical pharmacokinetic: Part II. Modeling. Compend Cont Educ_Pract Vet 1988;10:314-328.
6. Koritz GD. Practical aspects of pharmacokinetics for the large animal practitioner. Compend Cont Educ Pract Vet 1989;10:201-204.
7. Lee PID, Amidon GL. Pharamacokinetic analysis: a practical approach. Lancaster, VA: Technomic Publishing Co, Inc, 1996.
8. Gabrielsson J, Weiner D. Pharmacokinetic/pharmacodynamic data analysis: concepts and applications, 2nd ed. Apotekar societeten, Sweden, 1997.
9. Riviere JE. Basic principles and techniques of pharmacokinetic modeling. J Zoo Wildlife Med 1997;28:3-19.
10. Gibaldi M, Nagashima R, Levy G. Relationship between drug concentration in plasma or serum and amount of drug in the body. J Pharm Sci 1969;58:193-197.
11. Wagner JG. Significance of ratios of different volumes of distribution in pharmacokinetics. Biopharm Drug Disp 1983; 4:263-270.
12. Brown SA, Riviere JE. Comparative pharmacokinetics of aminoglycoside antibiotics. J Vet Pharmacol Ther 1991;14:1-35.
13. Atkinson AJ, Ruo TI, Frederiksen MC. Physiological basis of multicompartmental models of drug distribution. Trends in Pharm Sci 1991;12:96-101.
14. Ruckebusch Y, Phaneuf LP, Dunlop R. Physiology of small and large animals. Philadelphia: BC Decker, 1991;8-18.
15. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993;10:1093-1095.
16. Baggot JD. Pharmacokinetic-pharmcodynamic relationship. Ann Rech Vet 1990;21(Suppl 1):29-40.
17. Kurz H, Fichtl B. Binding of drugs to tissues. Drug Metab Rev 1983;14:467-510.
18. Sanders P, Moulin G, et al. Pharmacokinetics of spiramycin after intravenous, intramuscular and subcutaneous administration in lactating cows. J. Vet Pharmacol Ther 1992;15:53-61.
19. Hunter RP, Lynch MJ, Ericson JF, et al. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. J Vet Pharmacol Ther 1995;18:38-46.
20. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther 1996;19:1-14.
21. Debackere M. Veterinary medicine products: their pharmacokinetics in relation to the residue problem, in: Haagsma N, Ruiter A, Czedik-Eysenberg PB, eds. Proceedings EuroResidue Conf on Residues of Veterinary Drugs in Food. Netherlands. 1990;26-38.
22. Abadia AR, Aramayona JJ, Munoz MJ, et al. Disposition of ciprofloxacin following intravenous administration in dogs. J Vet Pharmacol Ther 1994;17:384-388.
23. Lobel RD, Varma KJ, Johnson JC, et al. Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther 1994;17:253-258.
24. 1-acid glycoproteins to plasma protein binding of some basic antimicrobials in pigs. J Vet Pharmacol Ther 1996;19:176-183.
25. Ames TR, Larson VL, Stowe CM. Oxytetracycline concentrations in healthy and diseased calves. Am J Vet Res 1983;44:1354-1357.
26. Clarke CR, Short CR, Corstvet RE, et al. Effect of Pasteurella haemolytica infection on the distribution of sulfadiazine and trimethoprim into tissue chambers implanted subcutaneously in cattle. Am J Vet Res 1989;50:1551-1556.
27. Baggot JD. Distribution of antimicrobial agents in normal and diseased animals. J Am Vet Med Assoc 1980;10:1085-1090.
28. van Miert, ASJPAM. Influence of febrile disease on the pharmacokinetics of veterinary drugs . Ann Rech Vet 1990;21(Suppl 1):11-28.
29. Groothuis DG, Gogh HW, van Miert ASJPAM. The effect of Escherichia coli endotoxin induced fever on the blood levels of antimicrobial drugs after intravenous and intramuscular administration in veal calves. In: van Miert ASJPAM, Frens J, van der Kreek PW, eds. Trends in veterinary pharmacology and toxicology. New York: Elsevier Scientific Publication Co. 1980;77-86.
30. Koshida R, Nakashima E, Taniguchi N, et al. Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts. Pharm Res 1989;6:486-491.
31. Wright LC, Horton CR, Jernigan AD, et al. Pharmacokinetics of gentamicin after intravenous and subcutaneous injection in obese cats. J Vet Phar Therap 1991;14:96-100.
32. Benet LZ, Zia-Amirhosseini P. Basic principles of pharmacokinetics. Tax Path 1995;23:115-123.
33. Rowland PE. Plasma protein binding displacement interaction - why are they still regarded as clinically important? Br J Clin Pharm 1994;37:125-128.
34. Smallwood RH, Mihaly GW, Smallwood RA, et al. Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction. J Pharm Biopharm1988;16:529-542.
35. Tozer TN. Implications of altered plasma protein binding in disease states. In: Benet LZ, Levy G, Ferraiolo BL, eds. Pharmacokinetic basis for drug treatment. New York: Raven Press. 1984;173-194.
36. Melander A, McLean A. Influence of food intake on presystemic clearance of drugs. Clin Pharmacokinetics 1983;8:2 86-296.
37. Walter-Sack I. The influence of nutrition on the systemic availability of drugs. Part II: drug metabolism and renal excretion. Klin Wochenschr 1987;65:1062-1072.
38. Riviere JE. Veterinary clinical pharmacokinetic: Part I. Fundamental concepts. Compend Cont Educ Pract Vet 1988;10: 24-31.